Vitro, S.A.B. de C.V. VITOF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.92% | 27.66% | 15.50% | 4.53% | -72.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.92% | 27.66% | 15.50% | 4.53% | -72.15% |
| Cost of Revenue | -31.80% | -8.32% | -52.75% | 36.45% | -92.37% |
| Gross Profit | 3.88% | 37.24% | 29.41% | -39.87% | -42.57% |
| SG&A Expenses | 12.30% | 16.11% | 17.06% | 17.54% | -32.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 219.57% | -46.81% | -363.51% | -89.74% | -22.61% |
| Total Operating Expenses | 22.54% | 10.07% | -6.34% | 26.31% | -72.38% |
| Operating Income | -242.21% | 79.57% | 117.63% | -157.76% | -69.70% |
| Income Before Tax | -141.60% | -34.62% | 26.59% | 207.26% | 194.72% |
| Income Tax Expenses | -120.64% | -1,785.70% | -18.56% | 955.46% | 416.10% |
| Earnings from Continuing Operations | -145.17% | 4.59% | 108.82% | 187.57% | 184.62% |
| Earnings from Discontinued Operations | -99.66% | -- | 543.72% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -138.18% | -18.59% | 418.29% | 187.57% | 200.00% |
| EBIT | -242.21% | 79.57% | 117.63% | -157.76% | -69.70% |
| EBITDA | -127.81% | 212.50% | 262.65% | -88.72% | -61.44% |
| EPS Basic | -127.50% | -25.00% | 302.49% | 200.00% | 271.43% |
| Normalized Basic EPS | -129.88% | -39.75% | -1.40% | 138.15% | 262.58% |
| EPS Diluted | -127.50% | -25.00% | 291.46% | 200.00% | 271.43% |
| Normalized Diluted EPS | -129.88% | -39.75% | -1.40% | 138.15% | 262.58% |
| Average Basic Shares Outstanding | 38.93% | 8.55% | 28.74% | -12.43% | -41.67% |
| Average Diluted Shares Outstanding | 38.93% | 8.55% | 28.74% | -12.43% | -41.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |